Home/Filings/4/0000795551-09-000003
4//SEC Filing

THERAGENICS CORP 4

Accession 0000795551-09-000003

CIK 0000795551operating

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 2:40 PM ET

Size

20.9 KB

Accession

0000795551-09-000003

Insider Transaction Report

Form 4
Period: 2009-02-26
Tarallo Francis J
Chief Financial Officer
Transactions
  • Award

    Theragenics Corporation common stock

    2009-02-26+18,00094,388 total
  • Award

    Theragenics Corporation common stock

    2009-02-26+9,15075,211 total
  • Award

    Stock Options (Right to Buy)

    2009-02-26+40,000146,200 total
    Exercise: $0.93Exp: 2019-02-26common stock (40,000 underlying)
Footnotes (6)
  • [F1]Represents the performance-based component of a performance restricted stock right. The filing person has previously reported 6,000 shares issuable under the time-based vesting componment of performance restricted stock rights ("performance rights"). The performance-based vesting component of the performance rights were not deemed beneficially owned under Section 16.
  • [F2]Rights granted for no consideration.
  • [F3]Restricted Stock Award vesting 25% annually, commencing on 2/26/10.
  • [F4]Restricted stock grant for no consideration
  • [F5]Aggregate shares include Common Stock owned through the Theragenics Employee 401(k) Savings Plan
  • [F6]Option Award exercisable at 25% annually, commencing on 2/26/10.

Issuer

THERAGENICS CORP

CIK 0000795551

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000795551

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 2:40 PM ET
Size
20.9 KB